(0.08%) 5 521.25 points
(0.11%) 39 889 points
(0.19%) 19 789 points
(0.01%) $81.64
(0.43%) $2.82
(-0.29%) $2 337.70
(0.02%) $29.53
(0.33%) $1 005.10
(0.01%) $0.932
(0.01%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
2 days till quarter result
(tns 2024-06-27)
Expected move: +/- 8.29%
0.49% $ 4.08
Live Chart Being Loaded With Signals
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 312 844 |
Średni wolumen | 36 282 |
Kapitalizacja rynkowa | 20.02M |
EPS | $-1.320 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $-1.100 ) 2024-06-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
13.60 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0630 (1.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-07 | Salsbury Michael | Buy | 5 051 | Common Stock |
2024-06-07 | Groves Jason L | Buy | 5 051 | Common Stock |
2024-06-07 | Koven Andrew I | Buy | 5 051 | Common Stock |
2024-06-07 | Glickman Mark A | Buy | 5 051 | Common Stock |
2024-06-07 | Strickland D Gordon | Buy | 5 051 | Common Stock |
INSIDER POWER |
---|
58.66 |
Last 74 transactions |
Buy: 14 128 459 | Sell: 2 890 534 |
Wolumen Korelacja
Neurobo Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
PCVX | 0.85 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neurobo Pharmaceuticals Korelacja - Waluta/Towar
Neurobo Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $7 000.00 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-2.46 |
FY | 2023 |
Przychody: | $7 000.00 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-2.46 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-28 000.00 (0.00 %) |
EPS: | $-19.01 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-28.27 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Neurobo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej